Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: Relationship with cell cycle regulators

Alterations in expression of retinoid receptors are implicated in human cancers. We hypothesized that altered expression of retinoic acid receptors (RARα,β,γ) and retinoid X receptor RXRα and their relationship with cell cycle regulators (p53, p16, p21) is associated with development, progression and prognosis of oral cancer. Immunohistochemical analysis of RAR α, β, γ and RXRα proteins was carried out on serial sections from 244 oral squamous cell carcinomas (OSCCs), 102 potentially malignant lesions (65 hyperplasias, 37 dysplasias), 83 matched histologically normal oral tissues and 29 normal mucosa from non‐exposed individuals without oral lesions and correlated with expression of cell cycle regulators p53, p16 and p21 as well as with clinicopathological parameters. Expression of retinoid receptors RARβ, RARγ, RXRα and cell cycle regulators p16 and p21 was decreased in majority of oral SCCs as well as in potentially malignant lesions. Multivariate stepwise logistic regression analysis carried out for comparison of non‐exposed normal oral mucosa with histologically normal oral tissues from patients with oral lesions showed significant loss of RARβ or p53 accumulation (RARβ−/p53+ Odd's ratio, OR = 266.6, p = 0.000); non‐exposed normal mucosa from individuals without oral lesions with potentially malignant lesion was RARβ−/p21−/p53+ (OR = 215.7, p = 0.000); matched normal to potentially malignant stage was RARα+/p21− (OR = 4.414, p = 0.005); hyperplasia to dysplasia was RARα+/p53+ (OR = 4.72, p = 0.005) and potentially malignant to malignant phenotype was RARα+ (OR = 2.061, p = 0.004). The prognostic relevance of these factors was assessed in 115 of these SCC patients who were followed‐up for a maximum period of 94 months (median 21 months). Multivariate analysis using Cox's proportional Hazard's model showed that RARα+/p21− phenotype was associated with shorter disease‐free survival (Hazard's ratio, HR = 1.863, p = 0.0471). To our knowledge, this is the first large study showing alterations in expression of retinoid receptors at the protein level at different stages in development and progression of oral SCC. It also underscored the prognostic significance of retinoid receptors and their interactions with cell cycle regulators in multistep oral tumorigenesis. © 2005 Wiley‐Liss, Inc.

[1]  R. Ralhan,et al.  Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. , 2004, Journal of experimental therapeutics & oncology.

[2]  R. Ralhan,et al.  Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. , 2003, Oral oncology.

[3]  E. Parkinson,et al.  Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-β: but p53 mutations are not necessarily required , 2003, Oncogene.

[4]  A. Tarrade,et al.  The AF-1 and AF-2 Domains of RARγ2 and RXRα Cooperate for Triggering the Transactivation and the Degradation of RARγ2/RXRα Heterodimers* , 2003, Journal of Biological Chemistry.

[5]  H. Schliephake,et al.  Prognostic relevance of molecular markers of oral cancer--a review. , 2003, International journal of oral and maxillofacial surgery.

[6]  R. Ralhan,et al.  Retinoic acid receptor‐alpha as a prognostic indicator in oral squamous cell carcinoma , 2003, International journal of cancer.

[7]  Daniel G. Tenen,et al.  Disruption of differentiation in human cancer: AML shows the way , 2003, Nature Reviews Cancer.

[8]  E. Parkinson,et al.  Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. , 2002, Cancer research.

[9]  M. Hung,et al.  Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells , 2002, Oncogene.

[10]  G. Snow,et al.  Nonmalignant Oral Keratinocytes from Patients with Head and Neck Squamous Cell Carcinoma Show Enhanced Metabolism of Retinoic Acid , 2002, Oncology.

[11]  R. Ralhan,et al.  Prognostic factors in betel and tobacco related oral cancer. , 2002, Oral oncology.

[12]  M. Dawson,et al.  Nicotine modulates the effects of retinoids on growth inhibition and RARβ expression in lung cancer cells , 2002, International journal of cancer.

[13]  Wei Zhang,et al.  The abnormal expression of retinoic acid receptor-beta, p 53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. , 2002, World journal of gastroenterology.

[14]  Rosalie C Sears,et al.  Signaling Networks That Link Cell Proliferation and Cell Fate* , 2002, The Journal of Biological Chemistry.

[15]  Shu-Chun Lin,et al.  The retinoic acid receptor-β (RAR-β) mRNA expression in the oral squamous cell carcinoma associated with betel quid use , 2002 .

[16]  S. Groshen,et al.  The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Lucia Altucci,et al.  The promise of retinoids to fight against cancer , 2001, Nature Reviews Cancer.

[18]  R. Lotan,et al.  Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RARβ and on retinoid resistance in human squamous carcinoma cells , 2001, Oncogene.

[19]  G. Snow,et al.  Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines , 2001, International journal of cancer.

[20]  D. Alberts,et al.  Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. , 2001, Cancer research.

[21]  Takemi Tanaka,et al.  Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors α and γ through proteasomes in mcf-7 human breast cancer cells , 2001 .

[22]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[23]  E. Dmitrovsky,et al.  Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function , 2001, Oncogene.

[24]  S. Lippman,et al.  Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. , 2001, Journal of the National Cancer Institute.

[25]  G. Snow,et al.  Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  S. Groshen,et al.  Retinoic acid receptor-α messenger RNA expression is increased and retinoic acid receptor-γ expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence , 2001 .

[27]  C. Berg,et al.  Secondary chemoprevention of upper aerodigestive tract tumors. , 2001, Seminars in oncology.

[28]  R. Lotan,et al.  Overexpression of Retinoic Acid Receptor β Induces Growth Arrest and Apoptosis in Oral Cancer Cell Lines , 2001, Japanese journal of cancer research : Gann.

[29]  M. Spitz,et al.  Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Takashi Suzuki,et al.  Retinoic Acid Receptor and Retinoid × Receptor in Ductal Carcinoma in situ and Intraductal Proliferative Lesions of the Human Breast , 2000, Japanese journal of cancer research : Gann.

[31]  D. Bok,et al.  Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: reduced expression of lecithin:retinol acyltransferase in carcinoma lines. , 2000, Carcinogenesis.

[32]  S. Lippman,et al.  Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  R. Ralhan,et al.  Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer. , 2000, The American journal of pathology.

[34]  O. Dalesio,et al.  EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. , 2000, Journal of the National Cancer Institute.

[35]  B. Min,et al.  Retinoic acid extends the in vitro life span of normal human oral keratinocytes by decreasing p16(INK4A) expression and maintaining telomerase activity. , 2000, Biochemical and biophysical research communications.

[36]  J. Califano,et al.  Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  D. Xiao,et al.  Orphan Receptor COUP-TF Is Required for Induction of Retinoic Acid Receptor β, Growth Inhibition, and Apoptosis by Retinoic Acid in Cancer Cells , 2000, Molecular and Cellular Biology.

[38]  N. Martinet,et al.  Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. , 1999, Journal of the National Cancer Institute.

[39]  R. Lotan,et al.  Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. , 1999, Cancer research.

[40]  P. Gupta Gutka: a major new tobacco hazard in India. , 1999, Tobacco Control.

[41]  S. Hsu,et al.  Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. , 1999, Experimental cell research.

[42]  R. Ralhan,et al.  MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications. , 1999, Oral oncology.

[43]  R. Ralhan,et al.  pRb and p16 protein alterations in human oral tumorigenesis. , 1998, Oral oncology.

[44]  J. Mork Forty years of monitoring head and neck cancer in Norway--no good news. , 1998, Anticancer research.

[45]  R. Ralhan,et al.  Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status. , 1998, Oral oncology.

[46]  R. Ralhan,et al.  Prognostic significance of p53 protein overexpression in betel‐ and tobacco‐related oral oncogenesis , 1998, International journal of cancer.

[47]  S. Chen,et al.  Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. , 1998, The Journal of clinical investigation.

[48]  L. Razanamahefa,et al.  Retinoic acid suppresses insulin-induced cell growth and cyclin D1 gene expression in human breast cancer cells. , 1998, International journal of oncology.

[49]  A. Børresen-Dale,et al.  Interaction between bcl‐2 and p21 (WAF1/CIP1) in breast carcinomas with wild‐type p53 , 1997, International journal of cancer.

[50]  D. Soutar,et al.  Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype. , 1997, Cancer research.

[51]  R. Lotan,et al.  Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. , 1997, Journal of the National Cancer Institute.

[52]  S. Piantadosi,et al.  Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.

[53]  J. Geradts,et al.  High frequency of aberrant p16(INK4A) expression in human breast cancer. , 1996, The American journal of pathology.

[54]  J S Lee,et al.  Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.

[55]  R. Ralhan,et al.  Overexpression of p53 protein in betel‐ and tobacco‐related human oral dysplasia and squamous‐cell carcinoma in India , 1994, International journal of cancer.

[56]  R. Lotan,et al.  Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. , 1994, Cancer research.

[57]  P. Boyle,et al.  Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem , 1994, Cancer Causes & Control.

[58]  S. Lippman,et al.  Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. , 1994, Journal of the National Cancer Institute.

[59]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer Treatment and Research.

[60]  R. Weber,et al.  Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. , 1993, The New England journal of medicine.

[61]  Rajanna,et al.  A population-based case-control investigation on cancers of the oral cavity in Bangalore, India. , 1990, British Journal of Cancer.

[62]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[63]  M. Spitz,et al.  Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. , 1989, International journal of radiation oncology, biology, physics.

[64]  P. Rubin,et al.  Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. , 1989, International journal of radiation oncology, biology, physics.

[65]  P. Boyle,et al.  RISING MORTALITY FROM CANCER OF THE TONGUE IN YOUNG SCOTTISH MALES , 1987, The Lancet.

[66]  W. Hong,et al.  13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.

[67]  B. Vikram Changing patterns of failure in advanced head and neck cancer. , 1984, Archives of otolaryngology.

[68]  M. Sporn,et al.  Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). , 1976, Federation proceedings.

[69]  V. Aa,et al.  Letter: Nutritional muscular dystrophy and human myocardial infarction. , 1973 .

[70]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[71]  V. Zoumpourlis,et al.  Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index , 2004, Virchows Archiv.

[72]  A. Tarrade,et al.  The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers. , 2003, The Journal of biological chemistry.

[73]  Shu-Chun Lin,et al.  The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use. , 2002, Journal of Oral Pathology & Medicine.

[74]  R. Ralhan,et al.  Expression of RARα and RARβ in human oral potentially malignant and neoplastic lesions , 2001 .

[75]  S. Groshen,et al.  Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. , 2001, Surgery.

[76]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[77]  L. D. De Luca,et al.  Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. , 2001, Biochemical pharmacology.

[78]  R. Oliver,et al.  Oral cancer in young adults: report of three cases and review of the literature. , 2000, British dental journal.

[79]  E. Nabeyrat,et al.  Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to p21(CIP1) downregulation. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[80]  H. de Thé Altered retinoic acid receptors. , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  S. Lippman,et al.  Retinoid chemoprevention of upper aerodigestive tract carcinogenesis. , 1992, Important advances in oncology.

[82]  J. Jacobs,et al.  Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. , 1991, International journal of radiation oncology, biology, physics.

[83]  S. Taylor Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[84]  C. Marth,et al.  Vitamin A status and retinoid-binding proteins in carcinomas of the head and neck region. , 1983, Oncology.